DeCipher leverages advanced AI models, ChatGPT3.5 and 4, specifically optimized for analyzing smart contracts. The resulting "smart contract-specialized GPT" is an incredibly precise tool that has ...
Decipher test scores are independently associated with biopsy upgrades in men on active surveillance for Gleason grade group 1 prostate cancer. Higher Decipher scores on the initial test are ...
GenomeDx Biosciences announced data from two studies showing that Decipher Prostate Cancer Classifier significantly altered treatment decisions and increased confidence in treatment decision-making ...
You could do worse than to confuse the meanings of "code" and "cipher"—even cryptographers sometime use the terms as though they had the same meaning. There is, however, a definite distinction between ...
The Decipher (GenomeDX Biosciences) test differentiates men at higher risk for prostate cancer metastasis after prostatectomy from those at lower risk and adds prognostic value in comparison with ...
Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients
Currently, there are multiple commercially available RNA-based biomarkers that are Medicare approved and suggested for use by the National Comprehensive Cancer Network guidelines. There is uncertainty ...
Bunzz PTE LTD, a Singapore-based tech company, is thrilled to announce the successful release of “DeCipher“, a revolutionary AI-powered tool designed to transform the process of generating smart ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results